朗玛信息 reported revenue of ¥0.12B for the period ended 2026-06-30, -18.2% year on year. Net income was ¥-0.01B, a -8.2% net margin on a 26.3% gross margin. The largest revenue line is 医疗服务 at 68% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | -18.2% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -175.4% |
| Gross margin | 26.3% | Net margin -8.2% |
| Revenue Q/Q | -10.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 医疗服务 | ¥0.09B | 68.4% |
| 医疗信息服务 | ¥0.02B | 19.9% |
| 移动转售业务 | ¥0.01B | 7.8% |
| 其他 | ¥0.00B | 2.6% |
| 医学人工智能服务 | ¥0.00B | 0.8% |
| IPTV业务及电话对对碰业务 | ¥0.00B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 73.7% |
| R&D | ¥0.01B | 6.7% |
| SG&A | ¥0.04B | 35.1% |
| Tax & other | ¥0.00B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥1.30B |
| Total liabilities | ¥0.22B |
| Shareholders' equity | ¥1.07B |
| Equity / assets | 82.9% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | -61% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
利德曼 ・ ST荣科 ・ 百纳千成 ・ 吴通控股 ・ 蓝英装备 ・ 博雅生物 ・ *ST三六五 ・ 利亚德 ・ 三诺生物 ・ 富春股份 ・ 海峡创新 ・ ST长方
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies